Annual Shareholders Equity
$368.84 M
+$29.94 M+8.83%
December 31, 2023
Summary
- As of February 8, 2025, IMCR annual stockholders equity is $368.84 million, with the most recent change of +$29.94 million (+8.83%) on December 31, 2023.
- During the last 3 years, IMCR annual shareholders equity has risen by +$293.42 million (+389.01%).
- IMCR annual shareholders equity is now at all-time high.
Performance
IMCR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$377.83 M
+$18.69 M+5.20%
September 30, 2024
Summary
- As of February 8, 2025, IMCR quarterly stockholders equity is $377.83 million, with the most recent change of +$18.69 million (+5.20%) on September 30, 2024.
- Over the past year, IMCR quarterly shareholders equity has increased by +$8.98 million (+2.44%).
- IMCR quarterly shareholders equity is now at all-time high.
Performance
IMCR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IMCR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.8% | +2.4% |
| 3 y3 years | +389.0% | +39.4% |
| 5 y5 years | +413.7% | +39.4% |
IMCR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.3% | at high | +89.2% |
| 5 y | 5-year | at high | +1804.5% | at high | +1850.9% |
| alltime | all time | at high | +1804.5% | at high | +1850.9% |
Immunocore Holdings Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $377.83 M(+5.2%) |
| Jun 2024 | - | $359.14 M(-0.1%) |
| Mar 2024 | - | $359.53 M(-2.5%) |
| Dec 2023 | $368.84 M(+8.8%) | $368.84 M(+3.7%) |
| Sep 2023 | - | $355.71 M(+1.7%) |
| Jun 2023 | - | $349.73 M(+3.0%) |
| Mar 2023 | - | $339.47 M(+0.2%) |
| Dec 2022 | $338.90 M | $338.90 M(+2.9%) |
| Sep 2022 | - | $329.22 M(+64.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $199.70 M(-6.9%) |
| Mar 2022 | - | $214.51 M(-7.4%) |
| Dec 2021 | $231.53 M(+207.0%) | $231.53 M(-14.6%) |
| Sep 2021 | - | $271.07 M(-11.8%) |
| Jun 2021 | - | $307.44 M(-9.0%) |
| Mar 2021 | - | $337.85 M(+347.9%) |
| Dec 2020 | $75.43 M(+289.5%) | $75.43 M(+277.1%) |
| Sep 2020 | - | $20.00 M(+3.3%) |
| Dec 2019 | $19.37 M(-73.0%) | $19.37 M |
| Dec 2018 | $71.80 M | - |
FAQ
- What is Immunocore Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Immunocore Holdings?
- What is Immunocore Holdings annual shareholders equity year-on-year change?
- What is Immunocore Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Immunocore Holdings?
- What is Immunocore Holdings quarterly shareholders equity year-on-year change?
What is Immunocore Holdings annual stockholders equity?
The current annual shareholders equity of IMCR is $368.84 M
What is the all time high annual shareholders equity for Immunocore Holdings?
Immunocore Holdings all-time high annual stockholders equity is $368.84 M
What is Immunocore Holdings annual shareholders equity year-on-year change?
Over the past year, IMCR annual stockholders equity has changed by +$29.94 M (+8.83%)
What is Immunocore Holdings quarterly stockholders equity?
The current quarterly shareholders equity of IMCR is $377.83 M
What is the all time high quarterly shareholders equity for Immunocore Holdings?
Immunocore Holdings all-time high quarterly stockholders equity is $377.83 M
What is Immunocore Holdings quarterly shareholders equity year-on-year change?
Over the past year, IMCR quarterly stockholders equity has changed by +$8.98 M (+2.44%)